Medicamen Organics (NSE:MEDIORG) Construction In Progress: ₹0.92 Mil (As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
32 GF Score
Price ₹23.80
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics Construction In Progress?

Medicamen Organics NSE:MEDIORG -4.99% 32 Construction In Progress is ₹0.92 Mil as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 32/100. The stock has 11 warning signs investors should review.

Medicamen Organics's quarterly construction in progress increased from Mar. 2024 (₹1.46 Mil) to Mar. 2025 (₹22.16 Mil) but then declined from Mar. 2025 (₹22.16 Mil) to Mar. 2026 (₹0.92 Mil).

Medicamen Organics's annual construction in progress increased from Mar. 2024 (₹1.46 Mil) to Mar. 2025 (₹22.16 Mil) but then declined from Mar. 2025 (₹22.16 Mil) to Mar. 2026 (₹0.92 Mil).

Medicamen Organics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics Construction In Progress Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 0.00 0.00 1.46 22.16 0.92

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
Construction In Progress Get a 7-Day Free Trial 0.00 0.00 1.46 22.16 0.92
NSE:MEDIORG
32GF Score
Medicamen Organics Ltd NSE:MEDIORG
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0.92 Mil mean?
Medicamen Organics (NSE:MEDIORG) has a Construction In Progress of ₹0.92 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Medicamen Organics and its competitors.
Is Medicamen Organics' Construction In Progress too high?
Medicamen Organics' current Construction In Progress is ₹0.92 Mil. Overall, Medicamen Organics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Construction In Progress compare to ZTS and UTHR?
Medicamen Organics' Construction In Progress of ₹0.92 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Medicamen Organics and its competitors. Medicamen Organics's current Construction In Progress is ₹0.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Construction In Progress of ₹0.92 Mil. The current Construction In Progress is ₹0.92 Mil. Medicamen Organics' overall GF Score™ is 32/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Construction In Progress is ₹0.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
32GF Score

Get the complete analysis for NSE:MEDIORG

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.80
Price